Why Do Vaccine Efficacy Rates Differ?

Morning Run · Morning Brief · 14 Jan 2021 · 11 mins listen

Pharmaniaga has inked a deal with Chinese biotech firm Sinovac to fill and finish 14 million doses of Covid-19 for Malaysians. But with questions starting to emerge over the efficacy of the Sinovac vaccine, we speak to Emeritus Professor Dr P.T. Thomas, Executive Dean at the Faculty of Health and Medical Sciences, Taylor's University, to help us understand vaccine approvals and some of the data coming out of different countries.

Image Credit: Shutterstock.com

Produced by:

Shazana Mokhtar

Presented by:

Lyn Mak,Noelle Lim,Roshan Kanesan

Categories:

none

Tags:

covid-19,vaccine,sinovac,efficacy rates,NPRA

Related Content

Health & Living · 13 Nov 2024 · 47 mins

Public Health: Why Was Pneumonia The Top Cause Of Death in 2023?

Azrul Mohd Khalib, CEO, Galen Centre for Health & Social PolicyProfessor Dr Ahmad Izuanuddin Ismail, President, Malaysian Thoracic SocietyDr Mohd Arif Mohd Zim, Consultant Respiratory Physician